Saturday 17 October 2026
Export ZJYL’s income statement to Excel — free account
Jin Medical International Ltd.
ZJYL Healthcare Medical Instruments & Supplies
Jin Medical International Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $20.7 million, down 12.0% from fiscal 2024.
2.08
0.08
−3.70%
Follow ZJYL
| Older periods | Sep '24 | Mar '25 | Sep '25 | Mar '26 | |
|---|---|---|---|---|---|
EV/Sales |
+4 more quarters Free account |
— | — | — | — |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.06 | 1.77 | 1.49 | 1.56 | |
Current Ratio |
2.50 | 2.11 | 1.86 | 1.95 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 5.13% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.10 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.61) | (15.62) | (27.28) | (14.04) | |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.02 | 0.02 | |
Free Cash Flow Yield |
— | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
— | — | — | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(1.35) | 0.51 | (3.72) | (2.72) | |
Working Capital |
25.66 | 23.04 | 20.35 | 21.73 | |
Capital Expenditures |
(0.14) | (2.05) | (6.63) | (1.79) | |
Net Current Asset Value |
25.57 | 23.01 | 20.35 | 18.87 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
6.34 | 7.44 | 7.19 | 5.49 | |
Average Payables |
3.56 | 3.84 | 3.32 | 2.87 | |
Average Inventory |
5.95 | 5.53 | 4.99 | 5.15 | |
Average Assets |
33.37 | 39.77 | 43.14 | 48.50 | |
Average Common Equity |
21.89 | 25.65 | 26.78 | 28.15 |
Columns are period end dates